Douglas E. James

The Potent BACE1 Inhibitor LY2886721 Elicits Robust Central Aβ Pharmacodynamic Responses in Mice, Dogs, and Humans

Patrick C. May, Brian A. Willis, Stephen L. Lowe et al. · Journal of Neuroscience · 2015 · 205 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17

Limiting hospital resources for acute appendicitis in children: Lessons learned from the U.S. epicenter of the COVID-19 pandemic

Charlotte Kvasnovsky, Yan Shi, Barrie S. Rich et al. · Journal of Pediatric Surgery · 2020 · 74 citations · Full text

Pharmacy, Child Health, Pediatrics +12

Profile of an American Amateur Rugby Union Sevens Series

Victor Lopez, Gregory J. Galano, Christopher M. Black et al. · The American Journal of Sports Medicine · 2011 · 72 citations

Medicine, Orthopaedic Surgery, Sports Medicine +13

The Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Relationships of Evacetrapib Administered as Monotherapy or in Combination With Statins

S Friedrich, JJP Kastelein, Douglas E. James et al. · CPT Pharmacometrics & Systems Pharmacology · 2014 · 17 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +17

Population Pharmacokinetics (PK) and Pharmacodynamics (PD) Analysis of LY3015014, a Monoclonal Antibody to Protein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Healthy Subjects and Hypercholesterolemia Patients

Tong Shen, Douglas E. James, Kathryn A. Krueger · Pharmaceutical Research · 2016 · 11 citations

Pharmacy, Pharmacokinetics, Pharmacology +11